We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
137 hedge funds and large institutions have $643M invested in Intra-Cellular Therapies Inc. in 2017 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 43 increasing their positions, 23 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
370% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 10
87% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 23
67% more capital invested
Capital invested by funds: $385M → $643M (+$258M)
37% more funds holding
Funds holding: 100 → 137 (+37)
51% less call options, than puts
Call options by funds: $6.91M | Put options by funds: $14.2M
Holders
137
Holders Change
+37
Holders Change %
+37%
% of All Funds
3.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
47
Increased
43
Reduced
23
Closed
10
Calls
$6.91M
Puts
$14.2M
Net Calls
-$7.33M
Net Calls Change
-$12.6M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.3M |
| 2 |
Millennium Management
New York
|
+$20.3M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.5M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$13.9M |
| 5 |
PA
Perceptive Advisors
New York
|
+$13.6M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$19.5M |
| 2 |
BlackRock
New York
|
-$7.95M |
| 3 |
Goldman Sachs
New York
|
-$5.18M |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.91M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$2.48M |
